30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Misonix Gains FDA Clearance for Nexus Ultrasonic Surgical Platform -

Misonix received FDA 510(k) clearance to market the Nexus ultrasonic surgical platform. Commercial U.S. launch will commence next month. Nexus combines all features of the company's existing products, including BoneScalpel ultrasonic bone cutting technology, plus SonicOne and Sonastar for other tissues, into a single fully-integrated offering driven by a proprietary digital algorithm that results in enhanced power, efficiency and control. RF capabilities support use in general surgery procedures, and Smart Technology enables ease of setup and use. Physicians will be able to utilize Nexus’ increased power to improve tissue resection rates, in concert with its proprietary digital algorithm to perform more efficient bone removal procedures. (Misonix, Inc., 6/3/19)